The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,246.00
Bid: 12,254.00
Ask: 12,256.00
Change: -72.00 (-0.58%)
Spread: 2.00 (0.016%)
Open: 12,324.00
High: 12,406.00
Low: 12,246.00
Prev. Close: 12,318.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar holds firm in cautious trading before Fed meets

Tue, 16th Mar 2021 04:29

* Yen hovers at nine-month lows, euro flat
* Focus on Fed comments about higher bond yields
* Sterling dips ahead of BoE meeting on Thursday
* Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

(Adds analyst comments; updates prices)
By Kevin Buckland and Sagarika Jaisinghani
TOKYO, March 16 (Reuters) - The U.S. dollar clung to small
gains on Tuesday as caution reigned in currency markets ahead of
major central bank meetings, beginning with a two-day Federal
Reserve gathering due to start later in the global day.
The greenback hovered just off its highest since June versus
the yen and cemented a position around $1.19 per euro
in muted trading.
The firmer tone for the dollar came despite a retreat in
U.S. benchmark yields from the highest levels in more than a
year ahead of the Fed meeting.
Expectations are running low for monetary policymakers to
shift from their accommodative stance despite forecasts of rapid
economic growth in the wake of an accelerating COVID-19 vaccine
roll-out and a $1.9 trillion pandemic relief package.

Investors will pore over whatever the Fed has to say about
the run-up in yields, which have risen on bets that economic
growth and inflation could prompt a faster-than-expected
normalisation of monetary policy.
"It's a very pivotal meeting from that perspective," said
Mayank Mishra, an FX strategist at Standard Chartered Bank in
Singapore.
"The other thing that is being awaited is any decision on
the supplemental leverage ratio (SLR) exemption. We don't expect
any explicit push back on back-end yields, but an extension of
the SLR can offer some relief to the market."
The SLR exemption, a regulatory break that allows big banks
to exclude reserve deposits and Treasuries from capital ratios,
is due to expire on March 31.
The dollar was little changed at 109.170 yen after rising to
a nine-month high of 109.365 on Monday. The Bank of Japan begins
a two-day policy meeting on Thursday, along with an extensive
policy review.
The euro was largely flat at $1.19330, languishing below
$1.20 since March 5. Europe's vaccine roll-out has been hampered
by the suspension of AstraZeneca shots in Germany,
France and other nations amid concerns about possible serious
side effects.
Sterling fell about 0.2% to $1.3871 ahead of a Bank
of England meeting on Thursday, where the central bank is
expected to keep its benchmark interest rate at its historic low
of 0.1% and its bond-buying programme unchanged.
The dollar's index against six major currencies was flat at
91.798 after rising nearly 0.2% on Monday.
The Australian dollar, viewed widely as a liquid
proxy for risk appetite, and the New Zealand dollar were
little changed against the U.S. dollar. The commodity-linked
currencies are on course to post their fourth straight quarterly
gain as commodity prices rebound on bets of economic growth.
Bitcoin, meanwhile, slipped to $54,198.64 following its jump
to a record $61,781.83 on Saturday.

========================================================
Currency bid prices at 0400 GMT
Description RIC Last U.S. Close Pct Change YTD Pct High Bid Low Bid
Previous Change
Session
Euro/Dollar $1.1934 $1.1929 +0.04% -2.32% +1.1937 +1.1923
Dollar/Yen 109.1550 109.1200 +0.06% +5.71% +109.2400 +109.1900
Euro/Yen 130.26 130.16 +0.08% +2.63% +130.3900 +130.1400
Dollar/Swiss 0.9266 0.9275 -0.10% +4.74% +0.9279 +0.9266
Sterling/Dollar 1.3869 1.3900 -0.21% +1.53% +1.3903 +1.3867
Dollar/Canadian 1.2478 1.2473 +0.05% -2.00% +1.2487 +1.2468
Aussie/Dollar 0.7752 0.7756 -0.05% +0.77% +0.7755 +0.7742
NZ 0.7195 0.7200 +0.00% +0.26% +0.7205 +0.7195
Dollar/Dollar


All spots
Tokyo spots
Europe spots
Volatilities
Tokyo Forex market info from BOJ



(Reporting by Kevin Buckland in Tokyo and Sagarika Jaisinghani
in Bengaluru; Editing by Christopher Cushing & Simon
Cameron-Moore)

More News
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.